DMAC8:30 AMDiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR ResultsResults Call • Phase 2Results call Fri, Oct 23, 2026, 8:00 AM ETGdiamedica.com
DMAC8:30 AMDiaMedica Therapeutics to Participate in Upcoming September Investor Conferencesdiamedica.com
DMAC4:30 PMDiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business HighlightsResults Call • Phase 2Results call Tue, Sep 1, 2026, 4:30 PM EDTGdiamedica.com
DMAC4:30 PMDiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026diamedica.com